UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013675
Receipt number R000015948
Scientific Title Study regarding appropriate intervals between two doses of varicella vaccine
Date of disclosure of the study information 2014/04/15
Last modified on 2015/12/05 11:24:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study regarding appropriate intervals between two doses of varicella vaccine

Acronym

Intervals between two doses of varicella vaccine

Scientific Title

Study regarding appropriate intervals between two doses of varicella vaccine

Scientific Title:Acronym

Intervals between two doses of varicella vaccine

Region

Japan


Condition

Condition

Varicella

Classification by specialty

Pediatrics Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We compare the antibody and CMI between 3-month-interval vaccinees and 12-month interval ones to confirm the efficacy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The IgG and IgM antibodies and CMI with interferon-gamma release assay before and at 1 and 13 months after vaccination.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Vaccine

Interventions/Control_1

A group with 3-month-interval of the two doses.

Interventions/Control_2

A group with 12-month-interval of the two doses.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

2 years-old <=

Age-upper limit

6 years-old >

Gender

Male and Female

Key inclusion criteria

Response of interferon-gamma is appropriate for over 2-year-old.Varicella vaccine is eligible under 6-year-old.

Key exclusion criteria

Not available for vaccination.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kihei Terada

Organization

Kawasaki Medical School

Division name

Pediatrics

Zip code


Address

577 Matsushima, Kurashiki-shi, Okayama-ken, 701-0192, Japan

TEL

086-462-1111

Email

kihei@med.kawasaki-m.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kihei Terada

Organization

Kawasaki Medical School

Division name

Pediatrics

Zip code


Address

577 Matsushima, Kurashiki-shi, Okayama-ken, 701-0192, Japan

TEL

086-462-1111

Homepage URL


Email

kihei@med.kawasaki-m.ac.jp


Sponsor or person

Institute

Kawasaki Medical School

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 04 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2014 Year 03 Month 15 Day

Date of IRB


Anticipated trial start date

2014 Year 04 Month 15 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 04 Month 10 Day

Last modified on

2015 Year 12 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015948


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name